Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with ovarian cancer

To compare the effectiveness and safety of weekly paclitaxel with that of three-weekly paclitaxel, in combination with carboplatin, as first-line chemotherapy treatment for ovarian cancer.

This is a protocol.

Share/Save
Health topics: